EHAVE, Inc. (OTCPK:EHVV.F) entered into a stock purchase agreement to acquire Rejuv IV Inc. on January 8, 2022. Rejuv IV will become KetaDASH, a wholly owned subsidiary of Ehave, Inc.

EHAVE, Inc. (OTCPK:EHVV.F) completed the acquisition of Rejuv IV Inc. for $0.27 million on January 8, 2022. As part of consideration, EHAVE, Inc. paid $50,000 on December 1, 2021, $25,000 cash payable over five months from the cash flows of Rejuv IV, Inc., and $175,000 of common stock of the EHAVE valued at the average closing price for five trading day immediately preceding the closing date of January 8, 2022. EHAVE issued 19,977,169 shares of common stock.